Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.
Did you miss last night's "Mad Money" on CNBC? If so, here are Jim Cramer's top takeaways for today's trading.
Everyone knows that printed checks are going the way of the dinosaur in today's online digital world, which is exactly why Deluxe hasn't been resting on its laurels. The company has been investing big into small business services including web hosting and logo design. But shares of Deluxe took a turn for the worse in 2015, when small business growth slowed.
However in January of this year, Deluxe got its groove back and predicts its business services will grow between 15% and 19% while its online business will grow in the low single digits, more than enough to offset slowing check sales.
The company is so confident in its prospects that Deluxe committed $300 million to a stock buyback to bolster shares which still trade at a scant 13 times earnings.
Cramer said if you look at Deluxe as just a check printer the stock isn't worth buying, but at a small business services company that also has a big buyback, the stock is very cheap in an environment where there aren't many cheap stocks left.
Kimco Realty(KIM) - Get Report : In an exclusive interview, Cramer sat down with Conor Flynn, president and CEO of Kimco Realty, the shopping center real estate investment trust with shares that are up 20% for 2016.
Flynn said that off-price retail is thriving right now and TJX Companies(TJX) - Get Report and Ross Stores(ROST) - Get Report are two of the gems that Kimco is proud to call tenants. He said these retailers are providing value and convenience, which is exactly what consumers are demanding.
Flynn said this is an exciting time for grocery stores as well, and many chains are testing the waters with drive-thru and same day deliveries of items. Likewise, other areas including beauty and pets continue to outperform.
When asked about some high-profile bankruptcies such as Sports Authority, Flynn explained that with so little supply, when a retailer vacates Kimco is able to sign new tenants typically at 30% higher rents.
Cramer reiterated his recommendation of Kimco.
Ionis Pharmaceuticals(IONS) - Get Report : In his second "Executive Decision" segment, Cramer also spoke with Dr. Stanley Crooke, chairman and CEO of Ionis Pharmaceuticals, the biotech that roared 30% today after the company announced positive Phase III results for its spinal muscular atrophy (SMA) treatment, Nusinersen.
Crooke explained that SMA is the leading genetic cause of infant death around the globe, with around 30,000 cases reported each year. He said nearly half of those babies have Type I SMA, which is what Nusinersen treats.
While most SMA babies die within eight to 10 months of age, Nusinersen has proven to greatly enhance developmental milestones like sitting, standing and even walking. He called the results "remarkable." So too did the FDA, which allowed Ionis to file interim results so that more babies can have access to Nusinersen before the study even finishes.
To read a full recap of "Mad Money" on CNBC, click here.
To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.
To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.
At the time of publication, Cramer's Action Alerts PLUS had no position in stocks mentioned.